Vaginal Endometriosis: An Enigma for Clinicians

  • Prerna LakhwaniEmail author
  • Kapil Kumar
Case report


Endometriosis is the presence of ectopic endometrial tissue that responds to hormonal stimulation. Although it occurs most often in pelvis, several unusual sites have been reported like skin, umbilicus, vagina, etc. The pivotal case here is a 19-year-old lady who presented with a vaginal polypoidal growth mimicking carcinoma vagina. She gave a history of irregular vaginal bleeding since 3 years and something protruding through the vagina periodically before and during menstrual period. It was accompanied by moderate-to-severe dysmenorrhea and persistent pain in right iliac fossa. MRI was suggestive of B/L Adnexal masses with focal soft tissue lesion involving Right posterolateral fornix. On EUA, patient had a 3 × 4 cm polypoidal tongue-like vascular growth arising from right posterolateral fornix which was totally excised using diathermy. The histological exam of the tissue showed features of endometriosis. The patient was managed by monthly i/m injections of Depot preparation of GnRH analogs for 6 months. The patient now is absolutely symptom free. EUA and excision followed by proper medical management allayed the anxiety of patient and her parents.


Endometriosis Vaginal endometriosis Medical management of endometriosis GnRH analogs in endometriosis 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Shroen D. Disputatio Inauguralis. Medica de Uleribus uteri. Jena Krebs. 1960;1690:6–17.Google Scholar
  2. 2.
    Choi SW, Lee HN, Kang SJ, Kim HO. A case of cutaneous endometriosis in postmenopausal woman receiving hormonal replacement. J Am Acad Dermatol. 1999;41(32):327–9.CrossRefGoogle Scholar
  3. 3.
    Martin JD Jr, Hauck AE. Endometriosis in the male. Am Surg. 1985;51(7):426–30.PubMedGoogle Scholar
  4. 4.
    Purvis RS, Tyring SK. Cutaneous and subcutaneous endometriosis: surgical and hormonal therapy. J Dermatol surg Oncol. 1994;20(10):693–5.CrossRefGoogle Scholar
  5. 5.
    Fedele L, Bianchi S, Zanconato G, Tozzi L, Raffaelli R. Gonadotropin-releasing hormone agonist treatment for endometriosis of the rectovaginal septum. Am J Obstet Gynecol. 2000;183:1462–7.CrossRefGoogle Scholar
  6. 6.
    Hefler LA, Grimm C, Van Trotsenburg M, Nagele F. Role of the vaginally administered aromatase inhibitor anastrazole in women with rectovaginal endometriosis: a pilot study. Fertil Steril. 2005;84:1033–6.CrossRefGoogle Scholar
  7. 7.
    Vercellini P, Crosignani PG, Somigliana E, Berlanda N, Barbara G, Fedele L. Medical treatment for rectovaginal endometriosis: what is the evidence? Hum Reprod. 2009;24(10):2504–14.CrossRefGoogle Scholar

Copyright information

© Association of Gynecologic Oncologists of India 2019

Authors and Affiliations

  1. 1.Fortis HospitalShalimar BaghIndia

Personalised recommendations